Similar patterns of weight regain have been observed after stopping liraglutide, another GLP-1 receptor agonist, and continued exercise, especially weight-bearing activities, is recommended to help prevent rebound weight gain
Additionally, thermosensitive nanogels and stimuli-responsive nanocarriers that respond to pH or glucose levels have been proposed for precision-controlled GLP-1 delivery, enabling intelligent drug release based on glycemic fluctuations
These downstream effects have contributed to clinical interest in GH secretagogue protocols within regenerative medicine contexts
It's almost like we're all walking around with GLP-1 deficiency, that if we had this present at higher levels around the clock, and of course eventually we'll see things that are well beyond obesity, how well this has an impact
Thiazide effects and adverse effects: insights from molecular genetics
Bariatric surgery, by contrast, provides a proven, lasting solution to obesity and its complications